Journal
ACTA BIOMATERIALIA
Volume 7, Issue 1, Pages 287-294Publisher
ELSEVIER SCI LTD
DOI: 10.1016/j.actbio.2010.09.004
Keywords
Polymeric paving; Aneurysm; Polycaprolactone; Polyurethane; Vascular grafts
Funding
- ARCS Foundation
- NIH [HL007955]
- NSF [0644570]
- NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007955] Funding Source: NIH RePORTER
Ask authors/readers for more resources
Polymeric endoaortic paving (PEAP) is a process by which a polymer is endovascularly delivered and thermoformed to coat or pave the lumen of the aorta. This method may offer an improvement to conventional endoaortic therapy in allowing conformal graft application with reduced risk of endoleak and customization to complex patient geometries. Polycaprolactone (PCL)/polyurethane (PU) blends of various blend ratios were assessed as a potential material for PEAP by characterizing their mechanical, thermoforming and degradation properties. Biaxial tension testing revealed that the blends' stiffness is similar to that of aortic tissue, is higher for blends with more PCL content, and may be affected by thermoforming and degradation. Tubes of blends were able to maintain a higher diameter increase after thermoforming at higher PCL content and higher heating temperatures; 50/50 blend tubes heated to 55 degrees C were able to maintain 90% of the diameter increase applied. Delamination forces of the blends ranged from 41 to 235 N m(-2). In a Pseudomonas lipase solution, the 50/50 blend had a 94% lower degradation rate than pure PCL, and the 10/90 blend exhibited no degradation. These results indicate that REAP, consisting of a PCL/PU blend, may be useful in developing the next generation of endoaortic therapy. (C) 2010 Acts Materialia Inc. Published by Elsevier Ltd. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available